Answers are grounded in this paper and cite their sources.
Introduction: Globally, ovarian carcinoma is the 7th most common cancer. Cancer antigen 125 (CA-125) is the most frequently used biomarker for ovarian cancer (OC). Carcinoembryonic antigen (CEA) is present only at very low levels in healthy adults and is raised in colon cancer, pancreatic malignancies, pancreatitis, cirrhosis, etc. The present study is to evaluate the ability of CEA in combination with CA-125 to differentiate epithelial ovarian malignancies from non-ovarian malignancies.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: